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 BACKGROUND 
 Human species does not synthesise vitamin B 12 (cobala-
min), and therefore the exogenous intake occurs through 
ingestion of animal products (ﬁ sh, meat and dairy prod-
ucts). 1 – 7 In developed countries, vitamin B 12 deﬁ ciency is 
found primarily in exclusively breastfed infants of mothers 
with deﬁ cit of this vitamin 1  3  4  6  8 – 10 : strict vegetarian or 
suffering from undiagnosed or untreated pernicious anae-
mia, 1 – 4  7 – 9  11  12 malnutrition or other serious malabsorption 
syndrome. 1  5  7 
 In Western countries, this disease is rare in infancy, 3–4  9 
with unknown incidence. 3 The cobalamin deﬁ cit presents 
biochemical, haematologic and neurologic manifestations 
and their reversibility depends on early intervention. 10  12 
 Given the rarity of this disease and the severity of its 
potential sequelae, we present the case of an infant exclu-
sively breastfed with severe vitamin B 12 deﬁ ciency, whose 
mother had undiagnosed pernicious anaemia, alert-
ing to vitamin B 12 deﬁ cit and the importance of adopt-
ing measures that prevent neurologic lesions potentially 
irreversible. 
 CASE PRESENTATION 
 A 10-month-old Caucasian girl, born after a normal full-
term pregnancy and delivery, whose Apgar scores were 
recorded as 9 and 10 at 1st and 5th min respectively, is 
described. Intrauterine growth restriction was apparent 
at birth weight of 2710 g (10–25th percentile), length 44.5 
cm (below the 10th percentile) and head circumference 32 
cm (10–25th percentile). First child of young parents not 
consanguineous, apparently healthy, asymptomatic and 
with no history of haematologic disease or other. Due to 
syndromic facies (facial dysmorphism with coarse facies, 
blepharophimosis, convex ﬁ lter with thin upper lip, micro-
gnathia, ankyloglossia) and intrauterine growth restriction, 
karyotype, skeletal radiography, cranial ultrasound, oph-
thalmologic examination and mucopolysaccharides and 
oligosaccharides study were made which did not show 
any ﬁ ndings. Since 5 months of age, weight percentile 
down crossing was noticed (from 50th percentile to below 
the 5th percentile) and also length and head circumference 
(from 25 to 50th percentile to below the 5th percentile 
( ﬁ gure 1 )). She was exclusively breastfed since birth. It 
was reported that the infant was reluctant to new foods 
and food diversiﬁ cation began only at 7 months of age and 
in trace quantities. At 10 months of age, the infant was 
admitted for intermittent vomiting, poor feeding, drowsi-
ness and prostration with 2 weeks of evolution. Physical 
examination revealed marked pallor, slightly jaundiced 
appearance, mild dehydration, generalised axial hypotonia 
and weak cry to stimulation. She was afebrile with nor-
mal blood pressure, shallow breathing, respiratory rate of 
30–40 cycles per minute, tachycardia with resting heart 
rate of 170 beats/min, a II/VI grade systolic murmur at the 
left sternal border and 3 cm hepatomegaly not crossing the 
midline and without palpable spleen. No signs of bleeding 
diathesis. 
 INVESTIGATIONS 
 She presented severe anaemia: erythrocytes 1.54×10 12 /l, 
haemoglobin 4.6 g/dl, haematocrit 12.8%, reticulocytes 
0.4%, 6160/μl (reference value (r.v.) 0.5–2.5%; 0.05–
0.1×10 6 /μl); mean corpuscular volume (MCV) 83 fL ( r.v. 
77–95 fL), white cell count 4900/μl, neutrophils 1484/
ml, 30.3% and platelets 150 000/μl. The peripheral blood 
smear showed anisomacrocytosis and no blasts. Lactate 
dehydrogenase (LDH) level was 11198 U/l (r.v. 100–140 
U/l), total bilirubin 2.4 mg/dl (r.v. 0.3–1.0 mg/dl), direct 
bilirubin 0.5 mg/dl (r.v. <0.3 mg/dl), aspartate transami-
nase 95 U/L (r.v. 22–44 UI/l), alanine aminotransferase 20 
U/l (r.v. 12–34 UI/l) and C reactive protein 2.2 mg/dl (r.v. 
0.5–1 mg/dl). Anaemia investigation: ferritin 156.5 ng/
ml (r.v. 10–82 ng/ml), transferrin 189 mg/dl (r.v. 202–364 
mg/dl), haptoglobin <1.94 mg/dl (r.v. 30–200 mg/dl), very 
decreased serum vitamin B 12 level 3.3 pg/ml (r.v. 187–1059 
pg/ml) and normal serum folic acid level 11.8 pg/ml (r.v. 
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3.5–16.1 pg/ml). The myelogram obtained by bone mar-
row puncture revealed a hypercellular marrow: myelo-
erythrocyte ratio reversed, erythroid hyperplasia, left shift 
and marked dyserythropoiesis, hyperplasia of the granu-
locytic series, some giant metamyelocytes; megakaryo-
cytic series: normal number and hypersegmented nuclei; 
some grade I and II rare ringed sideroblasts( ﬁ gure 2 ). 
Vitamin B 12 level in breast milk was also reduced – 1.4 
ng/ml (r.v. > 3 ng/ml). Later, genetic mutation was found 
on chromosome 16, gene 3.7 - α-thalassemia (-α/αα). 
Mother’s laboratory evaluation showed haemoglobin 8.5 
g/dl, haematocrit 24%, reticulocytes 1.7%, MCV 107 fL, 
mean corpuscular haemoglobin 37.9 pg (r.v. 25–33 pg), 
platelets 181 000/μl, neutrophils 2050/μl, peripheral blood 
smear with anisomacrocytosis, serum levels of vitamin 
B 12 – 41.6 pg/ml, normal serum folate and positive anti-
intrinsic antibody factor. In mother’s serial evaluations 
during pregnancy there was a progressive increase in 
MCV. A diagnosis of pernicious anaemia in the mother 
was established. There was spontaneous disappearance 
of anti-intrinsic factor antibody in 2–3 years. Father’s 
blood count was unremarkable. The diagnosis of infant 
megaloblastic anaemia attributed to severe reduction of 
vitamin B 12 intake. 
 DIFFERENTIAL DIAGNOSIS 
 Folate deﬁ ciency and other causes of vitamin B 12 deﬁ -
ciency were excluded. Also, other haemoglobinopathies 
and glucose-6-phosphate dehydrogenase deﬁ ciency were 
excluded. 
 TREATMENT 
 Red blood cells transfusion, cyanocobalamin (50 μg sub-
cutaneously, ﬁ ve doses; 100 μg, oral, per day for 1 month), 
folic acid (5 mg/day), and food diversiﬁ cation with thera-
pist training were provided to the infant. 
 OUTCOME AND FOLLOW-UP 
 Biochemical and haematologic remission were achieved 
after 1 week and 1 month, respectively ( table 1 ). Infant 
development was normalised at 24 months (including 
head circumference) ( ﬁ gure 1 ). Psychomotor development 
at 2 and 3 years was normal as also brain MRI. She remains 
clinically well with excellent school performance at 12 
years of age. 
 DISCUSSION 
 The level of vitamin B 12 in infants whose mothers lack this 
vitamin, is very precarious, 1  3 – 5  9 especially in those exclu-
sively breastfed. 1  3 – 5 In our case, exclusive breastfeeding 
associated with low levels of maternal cobalamin has con-
ditioned a deﬁ cit state of this vitamin. The normal new-
born has enough vitamin B 12 for 6–8 months, 
3  8 even in 
the presence of a restricted diet or inadequate absorption, 
so the signs and symptoms of disease occur after a normal 
 Figure 1  Head circumference evolution of the infant. 
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developmental period, 1  2  4  6 characteristically between the 
4th and 8th months of age, 1 – 3  8 as in this case. 
 Clinical manifestations are predominantly neurologic 
and haematologic, 9 but are often unspeciﬁ c. 1  3  4  8–9 The 
earliest signs include progressive lethargy, apathy, irritabil-
ity 1  5  6  8–9  13  14 and developmental delay with gross motor 
dysfunction which contributes to feeding difﬁ culties. 4 – 6 
 9  14 There occurs refusal to wean and refusal to solid 
food, vomiting and failure to thrive, 1  5  8–9  14 as in the case 
presented. There may be weakness, anorexia and weak 
cry, 6  8  9 and also hyporreﬂ exia, hypotonia and choreath-
etotic movements. 5  6  8–9  14 As the disease progresses, it 
may appear hypothermia, encephalopathy and coma. 8  9 
Lemon pale skin with slight jaundice due to intramedul-
lary haemolysis and erythematous tongue, 8  13 mild hepat-
osplenomegaly, diarrhea and palmar hyperpigmentation 9 
are also common ﬁ ndings. The case described presented 
lethargy, apathy, poor weight gain, vomiting, solid food 
refusal, pallor, mild jaundice and hepatomegaly. The evo-
lution to encephalopathy was interrupted by the timely 
diagnosis. 
 All blood cells lineage are affected. 9  13 Red blood cells 
vary in size and shape and are frequently larger than 
normal. 13 Anaemia is macrocytic (>100 fL) 9  11  13  14 and 
there is reticulocytopenia. 6  9  13 In some situations, mega-
loblastic anaemia morphology does not show the usual 
variations 15  16 and macrocytosis may be absent in indi-
viduals with microcytic anaemia such as iron deﬁ ciency 
anaemia, α or β-thalassemia or chronic inﬂ ammatory 
disease 11  13  15 – 17 as in this case. Granulocyte precursors 
are also hypersegmented 6  9  13 and megakaryocytes show 
similar  changes. 9  13 Megaloblastic anaemia is associated 
with ineffective erythropoiesis and haemolysis, and con-
sequently increased erythrocyte precursors and plasma 
iron, LDH and bilirubin levels, 8  13 ﬁ ndings found in this 
case. Pancytopenia may also be found. 4  9 Bone marrow 
smears shows a cellular bone marrow with megaloblastic 
changes, especially in the erythroid series. 13 
 In childhood, megaloblastic changes of cell lines may 
be due to deﬁ ciency of folate, vitamin B 12 or, less often, to 
inborn errors of metabolism of vitamin B 12 , folate, purine 
or pyrimidine. 1  6  13 Vitamin B 12 deﬁ ciency should always 
be considered in children with neurologic symptoms asso-
ciated with megaloblastosis and failure to thrive 8 and must 
be included in the differential diagnosis of failure to thrive, 
regression of psychomotor development and neurologic, 
 Figure 2  Medullar blood smears obtained by bone marrow puncture showed erythroblastic and granulopoietic hyperplasia, megaloblasts, 
giant metamyelocytes and hyperlobulated megakaryocytes. 
 Table 1  Haematologic evolution of the infant 
 
 3rd month 
 Hospital stay (days) 
 11th month  23rd month  1  2  4  6  8  30 
Haemoglobin (g/dl) (11.5–15.5) 10.4 4.6 7 6.4 7.9 8.6 9.3 11.7 13.6
Haematocrit (%) (40–54%) 30.4 12.8 19.6 18.0 21.3 24.4 27.7 34.2 39.2
Erythrocytes (×10 12 /l) (4.6–6.2) 4.04 1.54 2.33 2.16 2.55 2.81 3.16 4.09 5.46
White blood cells (×103/μl) (4.5–13.5) 11.8 4.9 2.9 5.4 3.1 2.7 4.4 7.5 9.3
Platelets (×103/μl) (150–400) 418 150 107 59 58 112 294 477 362
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psychiatric and haematologic manifestations. 3  10 The con-
ﬁ rmation of diagnosis is made by elevated urinary or serum 
methylmalonic acid and serum homocysteine levels and 
decreased vitamin B 12 serum levels. 
2  5  7  13 Methylmalonic 
acid, except when caused by inborn errors of metabolism, 1 
 6  13  18 is the most sensitive and speciﬁ c markers of preclini-
cal vitamin B 12 deﬁ ciency 
2  3  5–6  8  13  18 and is a useful tool 
for differentiating from folate deﬁ ciency. 18 Unfortunately, 
in this case, we have no data on urine methylmalonic acid 
before the beginning of the treatment. 
 In this case, the thalassaemia trait masked macrocyto-
sis and the absence of known mother’s anaemia delayed 
the diagnosis. Neutrophil hypersegmentation visible on 
peripheral blood smear, pancytopenia, abnormal ﬁ ndings 
in blood and bone marrow smears suggested the deﬁ cit of 
cobalamin. Frequently, vitamin B 12 and folate deﬁ ciency 
coexist, so they must be investigated together. It is the 
discovery of vitamin B 12 deﬁ ciency in a breastfed infant 
that leads to maternal diagnosis, usually mild and asymp-
tomatic. 12  14 Mothers with subclinical pernicious anaemia 
are not usually anaemic 4  5  8  12 and serum levels of vitamin 
B 12 frequently are at the lower limit of normal. 
8 
 Vitamin B 12 treatment is not well established. 
8 
Characteristically, treatment of infants with haematologic 
and neurologic manifestations includes 1 mg intramuscu-
lar vitamin B 12 , for 4 days, 
1 followed sometimes by large 
oral doses to replete stores. 1 There have been described 
intramuscular or subcutaneous hydroxicobalamin admin-
istration (1000 μg in adults), six doses, during several 
weeks, several times a week 7  18 or daily during 2 weeks, 
weekly until the haematocrit is normal and then monthly 
for life 13 or for 6 months in the presence of neurologic 
manifestations. 13 Red blood cells transfusion is also rec-
ommended for children with severe anaemia. 8  13  18 In our 
case, we chose initial subcutaneous cobalamin, followed 
by daily vitamin doses associated with folate. We also 
promoted the food diversiﬁ cation and training as a source 
of cobalamin. 
 After therapy, there are clinical improvement and nor-
malisation of haematologic and neurologic parameters. 1 
 4  9  13 In 12 h, bone marrow becomes normoblastic with 
complete recovery in 2–3 days. 13 After 1 week, there is 
increased reticulocyte count and 1 month later complete 
blood count returns to normal. 9  13 In this case, after cobala-
min administration and food diversiﬁ cation, there was sig-
niﬁ cant clinical improvement with regression of neurologic 
and haematologic ﬁ ndings. 
 Precocious treatment offers a dramatic improvement. 9  14 
 17 Cerebral atrophy and desmielinisation may reverse in 
several months 1 as well as growth velocity normalisation, 1 
which occurred in the case described, including micro-
cephaly reversibility. When not properly treated, these 
infants show poor weight gain, haematologic changes and 
irreversible neurologic consequences. 2  14 The extent and 
degree of disability depends on the deﬁ ciency severity and 
duration. 1  3  4  6–7  10  14 
 There are several cases of exclusively breastfed infants 
suffering from megaloblastic anaemia born to mothers 
with undiagnosed pernicious anaemia. However, this case 
had an exuberant clinical presentation with neurologic 
reversibility, which is rare in those described in the litera-
ture. It is also referred that the coexistence of vitamin B 12 
deﬁ ciency and thalassemia could have worsened the prog-
nosis by delaying the diagnosis which did not happen in 
this case. 
 Learning points 
 ▶  It is very important to keep high suspicion for the 
diagnosis of vitamin B 12 defi ciency in an exclusively 
breastfed infant with clinical and laboratory 
manifestations, even in the absence of macrocytosis 
and/or positive maternal anamnesis. 
 Anaemia and megaloblastosis may be late  ▶
consequences of vitamin B 12 defi ciency and its 
absence in children whose mothers have vitamin B 12 
defi ciency history should not exclude the diagnosis. 
 In the presence of reduced levels of cobalamin in  ▶
an infant, maternal causes of vitamin B 12 must be 
investigated and if the mother has a varied diet, other 
aetiologies must be investigated, such as pernicious 
anaemia. 
 In some cases like this one, the appreciation of the  ▶
progressive increase in MCV during pregnancy could 
have allowed primary prevention measures in the 
infant. 
 A precocious diagnosis of vitamin B  ▶ 12 defi ciency and 
appropriate measures can prevent neurologic lesions 
potentially irreversible. 
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